Hylenex Recombinant
Payments companies reported to CMS as associated with Hylenex Recombinant. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Hylenex Recombinant, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Hylenex Recombinant
These are the largest totals companies reported as associated with Hylenex Recombinant. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Louis Schott | Cincinnati, OH | Ophthalmology | $698.30 |
| Ramesh Kode | Cincinnati, OH | Ophthalmology | $690.58 |
| Jillian Zimmer | Cincinnati, OH | Optometrist | $468.80 |
| David Jacobs | Richmond, VA | Ophthalmology | $379.89 |
| John Thompson | Baltimore, MD | Ophthalmology | $375.39 |
| Stephan Dixon | Cincinnati, OH | Glaucoma Specialist | $271.69 |
| Saif Jaweed | Crestview Hills, KY | Ophthalmology | $263.45 |
| Patrick Mccann | Flushing, NY | Nurse Anesthetist, Certified Registered | $219.80 |
| Shawn Agee | Jacksonville, FL | Retina Specialist | $203.64 |
| Eve Zacharakos | Norwalk, CT | Nurse Anesthetist, Certified Registered | $201.70 |
Prescribed Hylenex Recombinant?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.